Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
ENO2 encodes one of the three enolase isoenzymes found in mammals. Additionally we are shipping ENO2 Kits (66) and ENO2 Proteins (41) and many more products for this protein.
Showing 10 out of 625 products:
Dog (Canine) Monoclonal ENO2 Primary Antibody for IHC (p) - ABIN319990
Soler-Federsppiel, Cras, Gheuens, Andries, Lowenthal: Human gamma gamma-enolase: two-site immunoradiometric assay with a single monoclonal antibody. in Journal of neurochemistry 1987
Show all 6 references for ABIN319990
Human Monoclonal ENO2 Primary Antibody for WB - ABIN393238
Mukhtarova: [Significance of neurospecific enolase determination in estimation of severity of hypoxic-ischemic injury of newborn brain]. in Georgian medical news 2010
Show all 5 references for ABIN393238
Human Polyclonal ENO2 Primary Antibody for EIA, IHC (p) - ABIN357944
Kotaska, Petrak, Kukacka, Kraus, Prusa: Anti-vimentin antibodies and neuron-specific enolase in children with neurofibromatosis type-1. in Neuro endocrinology letters 2007
Show all 2 references for ABIN357944
Human Polyclonal ENO2 Primary Antibody for EIA - ABIN358515
Forooghian, Cheung, Smith, OConnor, Dosch: Enolase and arrestin are novel nonmyelin autoantigens in multiple sclerosis. in Journal of clinical immunology 2007
Show all 2 references for ABIN358515
Cow (Bovine) Polyclonal ENO2 Primary Antibody for WB - ABIN2788574
Choudhuri, Maitra, Evans: Translation initiation factor eIF3h targets specific transcripts to polysomes during embryogenesis. in Proceedings of the National Academy of Sciences of the United States of America 2013
Human Polyclonal ENO2 Primary Antibody for DB - ABIN389972
Hares, Kemp, Rice, Gray, Scolding, Wilkins: Reduced axonal motor protein expression in non-lesional grey matter in multiple sclerosis. in Multiple sclerosis (Houndmills, Basingstoke, England) 2013
Endogenous eno2 mRNA was detected in the developing retina from 2 days post-fertilization (dpf), and by 12dpf was localized to the retinal ganglion cell, inner and outer nuclear layers.
Suggest that NSE may be a practical parameter that can be used to monitor TB activity and treatment response. Elevated serum NSE level originates, at least in part, from macrophages in granulomatous lesions.
HER2 (show ERBB2 Antibodies) and NSE serum levels were independent prognostic factors in patients with brain metastases in breast cancer. Serum HER2 (show ERBB2 Antibodies) and MMP-9 (show MMP9 Antibodies) appear to be associated with BM in metastatic BC patients. Their predictive value for BM still needs to be evaluated in further prospective studies.
this study shows that neuron-specific enolase level is both a predictive marker of epidermal growth factor receptor (EGFR (show EGFR Antibodies)) tyrosine kinase (show TXK Antibodies) inhibitors treatment and a prognostic marker in non-small cell lung cancer harboring EGFR (show EGFR Antibodies) mutations patients
The study aimed to identify a small set of genetic signatures that may reliably predict the individuals with a high genetic propensity to heroin addiction. A set of 4 genes (JUN (show JUN Antibodies), CEBPB (show CEBPB Antibodies), PRKCB (show PRKCB Antibodies), ENO2, or CEBPG (show CEBPG Antibodies)) could predict the diagnosis of heroin addiction with the accuracy rate around 85% in our dataset.
High neuron-specific enolase expression is associated with poor response to chemotherapy in small cell lung cancer.
In pregnant women developing preeclampsia, the levels of NSE remained high throughout pregnancy, compared to healthy women where the levels decline.
Serum neuron specific enolase was a useful marker in predicting subclinical brain damage following essential hypertension.
BALF and serum NSE, CEA (show CEACAM5 Antibodies), and CYFRA21.1 elevated in lung cancer, which had prompt value for pathology, especially significant for BALF.
Significant levels of CEA (show CEACAM5 Antibodies), CYFRA 21-1, NSE, and TSGF were detected in the serum. The amounts found were useful for diagnosing non-small cell lung cancer (NSCLC) patients who depended on the currently limited biomarker development.
CEA (show CEACAM5 Antibodies), NSE, CA125 (show MUC16 Antibodies) and pro-GRP (show LSM4 Antibodies) could serve as biomarkers for SCLC, and CEA (show CEACAM5 Antibodies) and CYFRA21-1 could serve as biomarkers for NSCLC. Pro-GRP (show LSM4 Antibodies), CA125 (show MUC16 Antibodies) and CEA (show CEACAM5 Antibodies) were related to the clinical stages of lung cancer
Plaque-associated microglial cells express gamma-enolase and cathepsin X (show CTSZ Antibodies).
we induced differentiation of mouse stromal cells to neuron-like cells and observed the activation of tissue-specific promoter of neuron-specific enolase in transgenic mice with the human bcl-2 (show BCL2 Antibodies) gene expressed only in neurons under the NSE promoter
This gene encodes one of the three enolase isoenzymes found in mammals. This isoenzyme, a homodimer, is found in mature neurons and cells of neuronal origin. A switch from alpha enolase to gamma enolase occurs in neural tissue during development in rats and primates.
enolase 2 (gamma, neuronal)
, enolase 2-like
, 2-phospho-D-glycerate hydro-lyase
, 2-phospho-D-glycerate hydrolyase
, neural enolase
, neuron specific gamma enolase
, neuron-specific enolase
, neurone-specific enolase
, gamma-subunit of enolase
, 2-phospho-D-glycerate hydro-lyase 2
, 2-phosphoglycerate dehydratase 2
, enolase 2
, leucine rich protein, B7